News
THEOplayer Is Latest Video Player to Integrate with Verimatrix Streamkeeper Multi-DRM
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced THEO Technologies has completed
GEVELOT S.A.: Weekly report of share buyback August 25, 2022
Axway ist Leader im aktuellen API Management-Report von Forrester
Axway, ein führender Anbieter von API-Management- und Integrationssoftware, ist im aktuellen Forrester Wave-Report „API Management Solutions, Q3 2022“, als Leader positioniert worden.
Axway war
Axway Named a Leader in Latest API Management Solutions Report
Axway (Euronext: AXW.PA), a leading provider of API management and integration software, is proud to announce that it has been positioned as a Leader in The Forrester Wave™: API Management
Pharnext Announces a €2.5m Loan Agreement with Néovacs
Condor Technologies nimmt den Handel an der Börse Euronext in Paris wieder auf
Wir freuen uns, Ihnen die Wiederaufnahme des Handels von Condor Technologies (MLMFI.PA) am 23. August an der Euronext Access Exchange in Paris mitteilen zu dürfen.
Die Wiederaufnahme des Handels
Condor Technologies to Reopen Trading on the Euronext Exchange in Paris
We are pleased to announce the reopening of the trading sessions on August 23rd for Condor Technologies (MLMFI.PA) on the Euronext Access Exchange in Paris.
The resumption of the trading
Richard Mortellaro Appointed as President and CEO of Eutelsat America Corp.
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) announced today that Richard Mortellaro has been appointed to the position of President and CEO of Eutelsat America
DGAP-News: Abivax announces a change in its governance
GEVELOT S.A.: Weekly report of share buyback August 15, 2022
GEVELOT S.A.: Weekly report of share buyback August 10, 2022
NANOBIOTIX: Voting Rights and Shares Capital of the Company
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Poxel Announces Extended Cash Runway with Debt Restructuring Agreement and Equity-linked Financing Facility
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
DGAP-News: Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval
GEVELOT S.A.: Weekly report of share buyback August 3, 2022
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Asaf Ashkenazi zum CEO von Verimatrix ernannt
Verimatrix (Euronext Paris: VMX) (Paris:VMX) hat heute die Ernennung von Asaf Ashkenazi zum Chief Executive Officer mit Wirkung zum 1. August 2022 bekannt gegeben. Amedeo D'Angelo, seit 2015
Kaufman & Broad SA: PRESS RELEASE OF THE HALF YEARLY FINANCIAL REPORT
Asaf Ashkenazi Named CEO of Verimatrix
Regulatory News:
Verimatrix (Euronext Paris: VMX) (Paris:VMX), today announced the appointment of Asaf Ashkenazi as Chief Executive Officer effective Monday, August 1st, 2022. Amedeo D’Angelo
Valbiotis meldet den Abschluss der Rekrutierung für die klinische Phase II/III-Studie REVERSE-IT mit TOTUM•63 gegen Prädiabetes in Partnerschaft mit Nestlé Health Science
Valbiotis (FR0013254851 - ALVAL, PEA/KMU-qualifiziert) (Paris:ALVAL), ein Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlicher Innovation zur Vorbeugung und Bekämpfung von
Valbiotis Announces Completion of Recruitment for the Phase II/III REVERSE-IT Clinical Study With TOTUM•63 Against Prediabetes, in Partnership With Nestlé Health Science
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA/SME eligible) (Paris:ALVAL), a Research and Development company committed to scientific innovation for preventing and combating metabolic and
GEVELOT S.A.: Weekly report of share buyback July 27, 2022
Axway Software: Accelerated Migration to Cloud Offerings
Regulatory News:
Axway Software's (Paris:AXW) Board of Directors, chaired by Pierre Pasquier, today approved the financial statements for the first half of 2022, which were subject to a limited
